PhRMA submits comments on CMS’s Part D specialty tier proposal
By Tom Wilbur | April 7, 2020
Yesterday, PhRMA submitted comments on a Centers for Medicare & Medicaid Services (CMS) proposed rule on policy and technical changes to Medicare Part D and Medicare Advantage.
Read More
Three reasons the Senate Finance package is the wrong approach for patients
By Tom Wilbur | August 26, 2019
For more than a decade, Medicare Part D has successfully provided seniors and people with disabilities comprehensive prescription drug coverage, while its unique market-based structure has kept...
Read More
Three things to know about the Part D GAO report
By Nicole Longo | August 16, 2019
The Government Accountability Office (GAO) recently released a new report looking at Medicare Part D and the role of Pharmacy Benefit Managers (PBMs) in the program. While the report provides a...
Read More
No matter how you structure it, government arbitration is wrong for Medicare drug coverage
By Nicole Longo | June 27, 2019
Despite concerns from a broad group of stakeholders, some in Washington continue to push for imposing government arbitration on Medicare drug coverage to set the price of a medicine....
Read More
What you should know: Government arbitration is the wrong way to change Medicare
By Juliet Johnson | June 10, 2019
As Washington looks to make changes to Medicare, there are right ways and wrong ways to address the challenges patients face. In recent weeks, policymakers have discussed imposing government...
Read More
The Department of Health and Human Services recently proposed a rule that would encourage using discounts negotiated between biopharmaceutical manufacturers and Part D plans to reduce patients’...
Read More
Ask About Adherence: OIG proposed rule to reform the rebate system could improve adherence
By Guest Contributor | May 15, 2019
Ask About Adherence is a blog series featuring Q&A’s with experts and new medication adherence resources. In this post, we are pleased to share a blog post from Leah L. Zullig, PhD.
Read More
Today, IQVIA released its Medicine Use and Spending in the U.S. – A Review of 2018 and Outlook to 2023 report – highlighting the drivers behind medicine price and spending trends, patient...
Read More
Event tomorrow: Improving access and affordability for America’s seniors
By Andrew Powaleny | May 7, 2019
Medicare Parts B and D have played an important role in providing seniors with access to the lifesaving treatments they need and have been successful in delivering value to both the health care...
Read More
Six policy solutions to help patients afford their insulin
By Holly Campbell | April 9, 2019
Updated on 08/12/2019 Dramatic improvements in how we treat diabetes have transformed the lives of patients, but too many struggle to afford their insulin and other medicines at the pharmacy...
Read More
Medicare Monday (100)
340B Spotlight (43)
Cost & Consequence (0)
